Sunday, December 07, 2025 | 05:49 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Wall Street rises for third day as Omicron fears ease; Dow up 223 points

Merck's at-home Covid-19 pill gets US approval; weekly jobless claims unchanged at 205,000

Wall Street, US stocks, S&P, Dow Jones
premium

Lewis Krauskopf, Medha Singh and Bansari Mayur Kamdar | Reuters
Wall Street's main indexes rose solidly for a third straight session on Thursday after more encouraging developments about the impact of the Omicron variant of the coronavirus, lifting the mood ahead of Christmas break.
 
The S&P 500 was near its intraday record high as most sectors gained. Industrials and consumer discretionary were the top-performing sectors, both up about 1.3%.
 
Vaccine makers AstraZeneca Plc and Novavax Inc said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far